Published in J Biol Chem on February 10, 2010
Functional specificity of ras isoforms: so similar but so different. Genes Cancer (2011) 1.30
Ras, an actor on many stages: posttranslational modifications, localization, and site-specified events. Genes Cancer (2011) 0.93
The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility. Nat Commun (2011) 0.89
The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster. BMC Genomics (2010) 0.86
Ubiquitination: Added complexity in Ras and Rho family GTPase function. Small GTPases (2011) 0.85
The deubiquitinating enzyme USP17 is associated with non-small cell lung cancer (NSCLC) recurrence and metastasis. Oncotarget (2013) 0.80
USP17 is required for clathrin mediated endocytosis of epidermal growth factor receptor. Oncotarget (2014) 0.77
How to Target Activated Ras Proteins: Direct Inhibition vs. Induced Mislocalization. Mini Rev Med Chem (2016) 0.76
The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions. PLoS One (2016) 0.75
The deubiquitinating enzymes USP4 and USP17 target hyaluronan synthase 2 and differentially affect its function. Oncogenesis (2017) 0.75
Hyperactive Ras in developmental disorders and cancer. Nat Rev Cancer (2007) 10.27
A genomic and functional inventory of deubiquitinating enzymes. Cell (2005) 9.36
Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol (2009) 8.85
Endomembrane trafficking of ras: the CAAX motif targets proteins to the ER and Golgi. Cell (1999) 6.42
An acylation cycle regulates localization and activity of palmitoylated Ras isoforms. Science (2005) 5.99
Ras signalling on the endoplasmic reticulum and the Golgi. Nat Cell Biol (2002) 4.91
To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer (2001) 4.86
Phospholipase Cgamma activates Ras on the Golgi apparatus by means of RasGRP1. Nature (2003) 3.66
H-ras but not K-ras traffics to the plasma membrane through the exocytic pathway. Mol Cell Biol (2000) 3.24
Thematic review series: lipid posttranslational modifications. CAAX modification and membrane targeting of Ras. J Lipid Res (2006) 3.07
Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets. Nat Rev Drug Discov (2007) 2.67
Rho Family GTPase modification and dependence on CAAX motif-signaled posttranslational modification. J Biol Chem (2008) 2.22
Sef is a spatial regulator for Ras/MAP kinase signaling. Dev Cell (2004) 2.04
Postprenylation CAAX processing is required for proper localization of Ras but not Rho GTPases. Mol Biol Cell (2005) 1.85
Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf. J Clin Invest (2004) 1.81
Differential modification of Ras proteins by ubiquitination. Mol Cell (2006) 1.80
Ras activation in Jurkat T cells following low-grade stimulation of the T-cell receptor is specific to N-Ras and occurs only on the Golgi apparatus. Mol Cell Biol (2004) 1.66
Exchange factors of the RasGRP family mediate Ras activation in the Golgi. J Biol Chem (2003) 1.63
IQGAP1 modulates activation of B-Raf. Proc Natl Acad Sci U S A (2007) 1.57
Absence of the CAAX endoprotease Rce1: effects on cell growth and transformation. Mol Cell Biol (2002) 1.56
Ras subcellular localization defines extracellular signal-regulated kinase 1 and 2 substrate specificity through distinct utilization of scaffold proteins. Mol Cell Biol (2008) 1.50
Distinct utilization of effectors and biological outcomes resulting from site-specific Ras activation: Ras functions in lipid rafts and Golgi complex are dispensable for proliferation and transformation. Mol Cell Biol (2006) 1.46
Recent developments in anti-cancer agents targeting the Ras/Raf/ MEK/ERK pathway. Recent Pat Anticancer Drug Discov (2009) 1.35
Ras isoform abundance and signalling in human cancer cell lines. Oncogene (2007) 1.30
Farnesyltransferase inhibitors: a detailed chemical view on an elusive biological problem. Curr Med Chem (2008) 1.27
Activation of the MAPK module from different spatial locations generates distinct system outputs. Mol Biol Cell (2008) 1.25
RAS: target for cancer therapy. Cancer Invest (2008) 1.18
USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. J Biol Chem (2009) 1.14
Inhibitors of chronically active ras: potential for treatment of human malignancies. Recent Pat Anticancer Drug Discov (2008) 1.12
The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. Genomics (2005) 1.06
DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. J Biol Chem (2003) 1.03
Endothelial nitric oxide synthase regulates N-Ras activation on the Golgi complex of antigen-stimulated T cells. Proc Natl Acad Sci U S A (2008) 1.03
Proteomic characterization of the dynamic KSR-2 interactome, a signaling scaffold complex in MAPK pathway. Biochim Biophys Acta (2009) 1.00
Ras and its signals diffuse through the cell on randomly moving nanoparticles. Cancer Res (2006) 0.99
Regional myocardial ischemia-induced activation of MAPKs is associated with subcellular redistribution of caveolin and cholesterol. Am J Physiol Heart Circ Physiol (2006) 0.94
The role of ARF1 and rab GTPases in polarization of the Golgi stack. Traffic (2005) 0.94
H-Ras does not need COP I- or COP II-dependent vesicular transport to reach the plasma membrane. J Biol Chem (2007) 0.93
Partial functional overlap of the three ras genes in mouse embryonic development. Oncogene (2007) 0.82
SOCS-3 regulates onset and maintenance of T(H)2-mediated allergic responses. Nat Med (2003) 2.20
Design, optimization and characterisation of polymeric microneedle arrays prepared by a novel laser-based micromoulding technique. Pharm Res (2010) 1.76
Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase. J Virol (2007) 1.67
Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid. Thorax (2013) 1.64
Skin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses. ACS Nano (2013) 1.58
miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production. Am J Respir Crit Care Med (2014) 1.45
The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce. PLoS One (2012) 1.38
SOCS2 can enhance interleukin-2 (IL-2) and IL-3 signaling by accelerating SOCS3 degradation. Mol Cell Biol (2005) 1.36
Suppressor of cytokine signaling-3 is recruited to the activated granulocyte-colony stimulating factor receptor and modulates its signal transduction. J Immunol (2002) 1.29
The myeloproliferative disorder-associated JAK2 V617F mutant escapes negative regulation by suppressor of cytokine signaling 3. Blood (2007) 1.27
Tyrosine phosphorylation disrupts elongin interaction and accelerates SOCS3 degradation. J Biol Chem (2003) 1.25
Deacetylase activity is required for recruitment of the basal transcription machinery and transactivation by STAT5. Mol Cell Biol (2003) 1.24
Siglec-E is up-regulated and phosphorylated following lipopolysaccharide stimulation in order to limit TLR-driven cytokine production. J Immunol (2009) 1.23
SOCS: role in inflammation, allergy and homeostasis. Trends Immunol (2004) 1.21
Substitution of pseudokinase domain residue Val-617 by large non-polar amino acids causes activation of JAK2. J Biol Chem (2008) 1.20
Inflammation markers are associated with cardiovascular diseases risk in adolescents: the Young Hearts project 2000. J Adolesc Health (2010) 1.20
Multiplex immunoassay for serological diagnosis of Mycobacterium bovis infection in cattle. Clin Vaccine Immunol (2008) 1.19
Correlation of mycobacterium tuberculosis specific and non-specific quantitative Th1 T-cell responses with bacillary load in a high burden setting. PLoS One (2012) 1.16
SOCS3 targets Siglec 7 for proteasomal degradation and blocks Siglec 7-mediated responses. J Biol Chem (2006) 1.16
USP17 regulates Ras activation and cell proliferation by blocking RCE1 activity. J Biol Chem (2009) 1.14
The deubiquitinating enzyme USP17 is highly expressed in tumor biopsies, is cell cycle regulated, and is required for G1-S progression. Cancer Res (2010) 1.14
Retracted Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization. Immunity (2012) 1.12
CD33 responses are blocked by SOCS3 through accelerated proteasomal-mediated turnover. Blood (2006) 1.12
Antibody-targeted nanoparticles for cancer therapy. Immunotherapy (2011) 1.11
A role of suppressor of cytokine signaling 3 (SOCS3/CIS3/SSI3) in CD28-mediated interleukin 2 production. J Exp Med (2003) 1.11
Antibody-mediated inhibition of cathepsin S blocks colorectal tumor invasion and angiogenesis. Clin Cancer Res (2009) 1.07
Antibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cells. Bioconjug Chem (2008) 1.07
The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. Genomics (2005) 1.06
Matching SOCS with function. Nat Immunol (2003) 1.05
DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. J Biol Chem (2003) 1.03
Regulation of CD4+ T-cell polarization by suppressor of cytokine signalling proteins. Immunology (2012) 1.01
SOCS2 regulates T helper type 2 differentiation and the generation of type 2 allergic responses. J Exp Med (2011) 1.01
Microneedle-mediated intradermal nanoparticle delivery: Potential for enhanced local administration of hydrophobic pre-formed photosensitisers. Photodiagnosis Photodyn Ther (2010) 1.01
The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling. Biochem J (2004) 0.98
Mechanisms of SOCS3 phosphorylation upon interleukin-6 stimulation. Contributions of Src- and receptor-tyrosine kinases. J Biol Chem (2005) 0.98
Gene delivery using dimethyldidodecylammonium bromide-coated PLGA nanoparticles. Biomaterials (2010) 0.94
CCL11 blocks IL-4 and GM-CSF signaling in hematopoietic cells and hinders dendritic cell differentiation via suppressor of cytokine signaling expression. J Leukoc Biol (2008) 0.94
Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection. Int J Nanomedicine (2012) 0.93
Cathepsin S from both tumor and tumor-associated cells promote cancer growth and neovascularization. Int J Cancer (2013) 0.93
Antibody conjugates and therapeutic strategies. Mol Interv (2005) 0.93
A novel FK506-like binding protein interacts with the glucocorticoid receptor and regulates steroid receptor signaling. Endocrinology (2008) 0.91
Antibody targeting of cathepsin S inhibits angiogenesis and synergistically enhances anti-VEGF. PLoS One (2010) 0.90
SOCS3 tyrosine phosphorylation as a potential bio-marker for myeloproliferative neoplasms associated with mutant JAK2 kinases. Haematologica (2009) 0.89
The deubiquitinating enzyme USP17 is essential for GTPase subcellular localization and cell motility. Nat Commun (2011) 0.89
Steroidogenic alterations and adrenal androgen excess in PCOS. Steroids (2006) 0.89
Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort study. BMC Pulm Med (2014) 0.89
Recombinant cathepsin S propeptide attenuates cell invasion by inhibition of cathepsin L-like proteases in tumor microenvironment. Mol Cancer Ther (2008) 0.89
Cathepsin S: therapeutic, diagnostic, and prognostic potential. Biol Chem (2015) 0.88
Cysteine cathepsins S and L modulate anti-angiogenic activities of human endostatin. J Biol Chem (2011) 0.87
Inhibition of Cathepsin S by Fsn0503 enhances the efficacy of chemotherapy in colorectal carcinomas. Biochimie (2011) 0.86
The DUB/USP17 deubiquitinating enzymes: a gene family within a tandemly repeated sequence, is also embedded within the copy number variable beta-defensin cluster. BMC Genomics (2010) 0.86
The chemoattractants, IL-8 and formyl-methionyl-leucyl-phenylalanine, regulate granulocyte colony-stimulating factor signaling by inducing suppressor of cytokine signaling-1 expression. J Immunol (2004) 0.85
The suppressors of cytokine signalling E3 ligases behave as tumour suppressors. Biochem Soc Trans (2008) 0.85
Ubiquitination: Added complexity in Ras and Rho family GTPase function. Small GTPases (2011) 0.85
Regulation of Foxp3+ inducible regulatory T cell stability by SOCS2. J Immunol (2013) 0.85
Enhanced antitumor activity of the photosensitizer meso-Tetra(N-methyl-4-pyridyl) porphine tetra tosylate through encapsulation in antibody-targeted chitosan/alginate nanoparticles. Biomacromolecules (2013) 0.84
Vasodilator-stimulated phosphoprotein regulates inside-out signaling of beta2 integrins in neutrophils. J Immunol (2010) 0.84
Hepatitis C virus targets the interferon-α JAK/STAT pathway by promoting proteasomal degradation in immune cells and hepatocytes. FEBS Lett (2013) 0.84
Cutting edge: suppression of GM-CSF expression in murine and human T cells by IL-27. J Immunol (2012) 0.83
Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination. J Pharm Pharmacol (2014) 0.83
Regulation of cellular responses by deubiquitinating enzymes: an update. Front Biosci (Landmark Ed) (2012) 0.83
Inhibition of secretion of interleukin (IL)-12/IL-23 family cytokines by 4-trifluoromethyl-celecoxib is coupled to degradation via the endoplasmic reticulum stress protein HERP. J Biol Chem (2010) 0.81
Antibody targeting of Cathepsin S induces antibody-dependent cellular cytotoxicity. Mol Cancer (2011) 0.81
Conatumumab (AMG 655) coated nanoparticles for targeted pro-apoptotic drug delivery. Biomaterials (2011) 0.81
A highly potent and specific MET therapeutic protein antagonist with both ligand-dependent and ligand-independent activity. Mol Cancer Ther (2013) 0.81
Stable expression and purification of a functional processed Fab' fragment from a single nascent polypeptide in CHO cells expressing the mCAT-1 retroviral receptor. J Immunol Methods (2011) 0.80
The deubiquitinating enzyme USP17 is associated with non-small cell lung cancer (NSCLC) recurrence and metastasis. Oncotarget (2013) 0.80
A new polycythaemia vera-associated SOCS3 SH2 mutant (SOCS3F136L) cannot regulate erythropoietin responses. Br J Haematol (2009) 0.80
Suppressor of cytokine signalling (SOCS) 1 and 3 enhance cell adhesion and inhibit migration towards the chemokine eotaxin/CCL11. FEBS Lett (2010) 0.79
PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis? Eur J Obstet Gynecol Reprod Biol (2005) 0.79
Exchange protein directly activated by cAMP 1 (Epac1) is expressed in human neutrophils and mediates cAMP-dependent activation of the monomeric GTPase Rap1. J Leukoc Biol (2011) 0.79